Meissa Vaccines, a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, has entered into a manufacturing agreement with Exothera, a Univercells company and full-service Contract Research Development and Manufacturing Organization (CRDMO). Exothera delivers customized process development and GMP manufacturing services for vaccines, viral vectors and nucleic acids. Under the agreement, Exothera will manufacture […]

NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2 million (about US$1.5 million). This brings total equity financing to £3.2 million and will enable the company to reach key milestones in progressing its differentiated NK cell therapy candidates into […]

ENPICOM, an innovative bioinformatics software engineering company, has secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital. This underscores investor confidence in ENPICOM’s vision, unique technological capabilities, and exceptional track record in serving customers in the pharmaceutical and biotech industries.

TransCure bioServices, a humanized mouse model CRO, has partnered with Preclina, a South Korean preclinical CRO specializing in autoimmune and inflammatory diseases. The partnership significantly expands TransCure’s reach into the APAC region, while also bolstering its service offerings to further enhance the quality of its research results.